Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates 

Go back to Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates 
(NASDAQ: TRVI) Delayed: 13.46 +0.06 (0.45%)
Previous Close $13.40    52 Week High
Open $13.48    52 Week Low
Day High $13.82    P/E N/A 
Day Low $13.31    EPS
Volume 640,253